ALTRINSIC GLOBAL ADVISORS LLC - Q1 2019 holdings

$2.17 Billion is the total value of ALTRINSIC GLOBAL ADVISORS LLC's 147 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 7.7% .

 Value Shares↓ Weighting
VOD BuyVODAFONE GROUP PLC NEWsponsored adr$114,511,000
+2.0%
6,298,764
+8.2%
5.28%
-1.7%
SLB BuySCHLUMBERGER LTD$77,096,000
+38.3%
1,769,469
+14.5%
3.56%
+33.2%
CMCSA BuyCOMCAST CORP NEWcl a$56,075,000
+18.4%
1,402,573
+0.8%
2.59%
+14.0%
CTSH BuyCOGNIZANT TECHNOLOGY SOLUTIOcl a$47,896,000
+56.4%
661,097
+37.0%
2.21%
+50.6%
PEP BuyPEPSICO INC$43,692,000
+12.0%
356,523
+1.0%
2.02%
+7.8%
BMY BuyBRISTOL MYERS SQUIBB CO$42,413,000
+50.6%
888,981
+64.1%
1.96%
+45.0%
HIG BuyHARTFORD FINL SVCS GROUP INC$36,039,000
+26.1%
724,843
+12.7%
1.66%
+21.4%
ICE BuyINTERCONTINENTAL EXCHANGE IN$34,932,000
+1.9%
458,787
+0.8%
1.61%
-1.9%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$31,422,000
+12.2%
280,904
+1.1%
1.45%
+8.0%
TAP BuyMOLSON COORS BREWING COcl b$31,143,000
+7.1%
522,103
+0.9%
1.44%
+3.2%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$29,762,000
+71.1%
85,792
+40.6%
1.37%
+64.7%
EXC BuyEXELON CORP$28,262,000
+12.1%
563,783
+0.8%
1.30%
+7.9%
KR BuyKROGER CO$26,836,000
-9.9%
1,090,877
+0.7%
1.24%
-13.2%
PEG BuyPUBLIC SVC ENTERPRISE GRP IN$25,617,000
+15.5%
431,187
+1.2%
1.18%
+11.2%
BIIB BuyBIOGEN INC$25,549,000
-9.3%
108,085
+15.4%
1.18%
-12.7%
QCOM BuyQUALCOMM INC$23,731,000
+0.5%
416,124
+0.3%
1.10%
-3.2%
JWN BuyNORDSTROM INC$23,159,000
+13.3%
521,844
+19.0%
1.07%
+9.2%
FDX BuyFEDEX CORP$21,714,000
+14.6%
119,694
+1.9%
1.00%
+10.4%
CVS BuyCVS HEALTH CORP$19,229,000
+11.9%
356,541
+36.0%
0.89%
+7.8%
COG BuyCABOT OIL & GAS CORP$17,873,000
+17.4%
684,791
+0.5%
0.82%
+13.0%
EOG BuyEOG RES INC$17,464,000
+10.0%
183,483
+0.8%
0.81%
+5.9%
BKR BuyBAKER HUGHES A GE COcl a$17,405,000
+29.8%
627,897
+0.7%
0.80%
+24.9%
SABR BuySABRE CORP$15,367,000
-0.6%
718,435
+0.6%
0.71%
-4.3%
APA BuyAPACHE CORP$15,082,000
+32.8%
435,119
+0.6%
0.70%
+27.9%
SPNE BuySEASPINE HLDGS CORP$8,706,000
-12.4%
577,301
+5.9%
0.40%
-15.7%
TRUP BuyTRUPANION INC$5,286,000
+46.8%
161,450
+14.1%
0.24%
+41.0%
SGMO BuySANGAMO THERAPEUTICS INC$3,973,000
-8.9%
416,500
+9.6%
0.18%
-12.4%
PRQR BuyPROQR THRAPEUTICS N V$2,761,000
-3.5%
199,060
+9.8%
0.13%
-7.3%
CSU BuyCAPITAL SR LIVING CORP$2,338,000
-34.6%
586,007
+11.4%
0.11%
-36.8%
L BuyLOEWS CORP$2,084,000
+15.0%
43,472
+9.2%
0.10%
+10.3%
SHG BuySHINHAN FINANCIAL GROUP CO Lspn adr restrd$1,775,000
+63.0%
47,773
+55.8%
0.08%
+57.7%
NTES BuyNETEASE INCsponsored adr$1,751,000
+102.9%
7,253
+97.8%
0.08%
+97.6%
XENE BuyXENON PHARMACEUTICALS INC$1,626,000
+71.7%
160,000
+6.7%
0.08%
+66.7%
EHC BuyENCOMPASS HEALTH CORP$1,626,000
+3.5%
27,841
+9.3%
0.08%0.0%
CSCO BuyCISCO SYS INC$1,514,000
+36.2%
28,040
+9.3%
0.07%
+32.1%
CFMS BuyCONFORMIS INC$1,379,000
+795.5%
478,942
+11.7%
0.06%
+814.3%
ARA BuyAMERICAN RENAL ASSOCIATES HO$1,351,000
-2.2%
220,000
+83.3%
0.06%
-6.1%
DRNA NewDICERNA PHARMACEUTICALS INC$1,319,00090,000
+100.0%
0.06%
AGTC BuyAPPLIED GENETIC TECHNOL CORP$1,286,000
+109.1%
306,900
+24.3%
0.06%
+103.4%
ELGXQ NewENDOLOGIX INC$859,000130,000
+100.0%
0.04%
FITB BuyFIFTH THIRD BANCORP$732,000
+17.1%
29,041
+9.3%
0.03%
+13.3%
FTSV NewFORTY SEVEN INC$355,00021,957
+100.0%
0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KINROSS GOLD CORP42Q3 20235.5%
BP PLC42Q3 20236.3%
COMCAST CORP NEW42Q3 20233.0%
PUBLIC SVC ENTERPRISE GRP IN42Q3 20232.7%
CISCO SYS INC42Q3 20232.4%
ORACLE CORP40Q1 20232.1%
VODAFONE GROUP PLC NEW39Q3 20237.5%
INTERCONTINENTAL EXCHANGE INC.37Q3 20234.5%
PEPSICO INC37Q2 20223.0%
EOG RES INC36Q3 20231.5%

View ALTRINSIC GLOBAL ADVISORS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ALTRINSIC GLOBAL ADVISORS LLC Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Diversicare Healthcare Services, Inc.Sold outFebruary 10, 202200.0%
AAC Holdings, Inc.Sold outFebruary 12, 202100.0%
trivago N.V.Sold outFebruary 13, 201900.0%
TearLab CorpSold outFebruary 14, 201800.0%
FOSTER WHEELER AGFebruary 13, 20141,488,2361.5%
COOPER COMPANIES INCFebruary 08, 201071,5000.1%
ADVOCAT INCJanuary 14, 2010443,9528.0%

View ALTRINSIC GLOBAL ADVISORS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-10

View ALTRINSIC GLOBAL ADVISORS LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2166725000.0 != 2166729000.0)

Export ALTRINSIC GLOBAL ADVISORS LLC's holdings